Relationship Between Treatment With Bach´s Flower Remedy and Spiritual Well-Being of People With Common Mental Disorder
1 other identifier
interventional
70
1 country
1
Brief Summary
The Common Mental Disorders (CMD) refer to health states involving non-psychotic psychiatric symptoms. Part of this broad diagnostic category, symptoms such as difficulty concentrating, forgetfulness, insomnia, fatigue, irritability, feelings of worthlessness, somatic complaints, etc. The CMD has a big social impact, and its prevalence in the general population is 25% and graduate students in health care reaches 40%. The Bach´s Flower Remedies are considered a complementary therapy approved and recommended by World Health Organization and by the Brazilian Ministry of Health and in his theory it has great spiritual nature. In addition, international scientific research have suggested that the strengthening of spiritual well-being can help significantly and positively promoting mental health. This project aims to assess the relationship between treatment with Bach´s Flower Remedies and Spiritual well-being of people with Common Mental Disorders in undergraduate health students of a university located in São José dos Campos, state of São Paulo, Brazil. This research presents a quantitative and qualitative methodology, experimental clinical trial, triple blind. The treatment will take place with two groups of forty people, the group of treatment and the placebo´s. The trial will happen in six sessions at intervals of 30 days, totaling eight months of treatment. Statistical analysis will be used chi-square or Fisher exact test to study the association between the scale of spiritual well-being and the use of Bach Flowers for each time point (3 times). To compare the evolution of the results (scales) during the study will set a model for ordinal data with repeated measurements over time. For these statistical tests is assumed a significance level of 5% (p \< 0.005).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Feb 2011
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedFirst Submitted
Initial submission to the registry
February 21, 2011
CompletedFirst Posted
Study publicly available on registry
March 29, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedJanuary 18, 2012
March 1, 2011
10 months
February 21, 2011
January 16, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Self-Reporting Questionnaire (SRQ-20)
The Self-Reporting Questionnaire was developed by Harding et al. (1980), from four other instruments used for screening for possible mental disorders. The development of this instrument was coordinated by World Health Organization (WHO) and aimed to reach a possible instrument to identify cases in primary care services and community, especially in developing countries with lack of services and professionals. The intention of the WHO was to identify cases from the instrument and to encourage planners to provide services and mental health care to the needy population (WHO, 1994).
(8 months) In 3 times: the first one in the first visit, the second one in the third visit and the last one in the sixth visit.
Secondary Outcomes (1)
Spiritual Index of Well-Being Scale (SIWBS)
(8 months) 3 times after the intervention: the first one in the first visit, the second one in the third visit and the last one in the sixth visit
Study Arms (2)
Placebo group
PLACEBO COMPARATORIs the group of subjects that will take placebo
experimental group
EXPERIMENTALIs the group of subjects that will take Bach´s Flower remedies
Interventions
The subjects will have 4 drops 4 times per day, for approximately 8 months.
The subjects will have a solution non-drug type, 4 drops 4 times per day, for approximately 8 months
Eligibility Criteria
You may qualify if:
- People over 18 years old
- People who have read and agreed to participate by signing an informed consent
- People who obtain scores equal to or above 8 for women and equal to or above 6 for men in SRQ - 20
- People who does not ingest medication
- People who does not use any type of complementary therapy and integrative such as Herbal Medicine, Aromatherapy, Homeopathy, Flower Essences, Reiki, acupuncture, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UPECLIN HC FM Botucatu Unesplead
- University of Sao Paulocollaborator
- Universidade do Vale do Paraíbacollaborator
Study Sites (1)
University of Vale do Paraíba
São José dos Campos, São Paulo, 12244000, Brazil
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ivan A Guerrini, PhD
Medical School of São Paulo State University (UNESP)
- STUDY CHAIR
Ruth Turrini, PhD
Nursing School of University of São Paulo - (EEUSP)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc, Doctoral degree
Study Record Dates
First Submitted
February 21, 2011
First Posted
March 29, 2011
Study Start
February 1, 2011
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
January 18, 2012
Record last verified: 2011-03